DNA vaccines: designing strategies against parasitic infections - Wikidata - thesis-toulmin - TriplyDB

DNA vaccines: designing strategies against parasitic infections

DNA vaccines: designing strategies against parasitic infections

http://www.wikidata.org/entity/Q24801950

about

Vaccines for preventing cutaneous leishmaniasis Prime-boost vaccination with plasmid and adenovirus gene vaccines control HER2/neu+ metastatic breast cancer in mice.Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.Th1 Platform Immune Responses Against Leishmania major Induced by Thiol-Specific Antioxidant-Based DNA Vaccines Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine.Modulation of the immune response to the severe acute respiratory syndrome spike glycoprotein by gene-based and inactivated virus immunization.Co-administration of avian influenza virus H5 plasmid DNA with chicken IL-15 and IL-18 enhanced chickens immune responses.Heavy metals analysis, phytochemical, phytotoxic and anthelmintic investigations of crude methanolic extract, subsequent fractions and crude saponins from Polygonum hydropiper L.Research advances in microneme protein 3 of Toxoplasma gondii.Evaluation of the Impact of Codon Optimization and N-Linked Glycosylation on Functional Immunogenicity of Pfs25 DNA Vaccines Delivered by In Vivo Electroporation in Preclinical Studies in Mice Protective effect of lectin from Synadenium carinatum on Leishmania amazonensis infection in BALB/c mice.Induction of T helper 1 response by immunization of BALB/c mice with the gene encoding the second subunit of Echinococcus granulosus antigen B (EgAgB8/2).Enhancement of DNA tumor vaccine efficacy by gene gun-mediated codelivery of threshold amounts of plasmid-encoded helper antigen.Immune responses in DNA vaccine formulated with PMMA following immunization and after challenge with Leishmania major Progress in the development of genetic immunization.DNA vaccination by electroporation and boosting with recombinant proteins enhances the efficacy of DNA vaccines for Schistosomiasis japonica.In vivo electroporation of minicircle DNA as a novel method of vaccine delivery to enhance HIV-1-specific immune responses.The future for vaccine development against Entamoeba histolytica.Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii.Recent advances in Toxoplasma gondii immunotherapeutics.Inclusion of the bovine neutrophil beta-defensin 3 with glycoprotein D of bovine herpesvirus 1 in a DNA vaccine modulates immune responses of mice and cattle.Safety, immunogenicity, and cross-species protection of a plasmid DNA encoding Plasmodium falciparum SERA5 polypeptide, microbial epitopes and chemokine genes in mice and olive baboons.Immunogenicity and malaria transmission reducing potency of Pfs48/45 and Pfs25 encoded by DNA vaccines administered by intramuscular electroporation.Cloning of a Recombinant Plasmid Encoding Thiol-Specific Antioxidant Antigen (TSA) Gene of Leishmania majorand Expression in the Chinese Hamster Ovary Cell Line.Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.Comparative Assessment of Induced Immune Responses Following Intramuscular Immunization with Fusion and Cocktail of LeIF, LACK and TSA Genes Against Cutaneous Leishmaniasis in BALB/c Mice.Protective Efficacy of Coccidial Common Antigen Glyceraldehyde 3-Phosphate Dehydrogenase (GAPDH) against Challenge with Three Eimeria Species.Immunogenicity and efficacy of a bivalent DNA vaccine containing LeIF and TSA genes against murine cutaneous leishmaniasis.Protective capacity of cercarial transformation fluid alone or in combination with crude cercarial antigen against challenge infections of Schistosoma mansoni in mice.Chimeric DNA vaccines encoding Eimeria acervulina macrophage migration inhibitory factor (E.MIF) induce partial protection against experimental Eimeria infection.Approaches towards DNA vaccination against a skin ciliate parasite in fish.Immune response in susceptible BALB/c mice immunized with DNA encoding Lipophosphoglycan 3 of Leishmania infantum.OPTIMIZER: a web server for optimizing the codon usage of DNA sequences.Comparative functional potency of DNA vaccines encoding Plasmodium falciparum transmission blocking target antigens Pfs48/45 and Pfs25 administered alone or in combination by in vivo electroporation in rhesus macaques.Analysis of the protective potential of antigens released by Leishmania (Viannia) shawi promastigotes.New adjuvants in evolving vaccine strategies.Induction of Immune Responses by DNA Vaccines Formulated with Dendrimer and Poly (Methyl Methacrylate) (PMMA) Nano-Adjuvants in BALB/c Mice Infected with Leishmania major.Leishmania vaccines: from leishmanization to the era of DNA technology Protective immunity induced by Eimeria common antigen 14-3-3 against Eimeria tenella, Eimeria acervulina and Eimeria maxima

P2860

Q24240664-646B75FC-4130-48E4-B233-FE78660129C7 Q24813328-D30C2335-2CF7-4E94-BF3B-D2D16300AD35 Q33656471-4953845F-7769-470D-B4E3-BD24138B5200 Q34068700-8ABD8960-E34D-4F72-AA37-EAA45B20FFD9 Q34071134-D09A6908-4118-420B-914F-DC6B5DD865A9 Q34123950-927786E0-A039-4408-8B79-B8E8E965F6E3 Q34367306-D60E6A4A-F80A-46A9-9F1A-2C958F00D181 Q35487257-87A5D68E-77E1-44A2-AC24-FC0BA1A2D796 Q35875290-EDBC41E7-F71C-4719-8843-44CF290DF74E Q35998776-C0BB62DB-FC53-416D-8BD9-8F72E680D897 Q36868147-0A1F1136-6130-4DD1-AD61-0A67F009CACE Q36899214-130F6037-BAE9-4683-9F3D-25B6FF10445F Q37039140-9E3646F9-02A6-477B-A313-04E7FBD704E1 Q37053209-66EDCF0A-9D7E-4004-85F7-8A2487DB7138 Q37316018-3093CFFE-4989-428A-A8AD-BDCBBFFE1B4B Q37450878-878FD9D4-62CF-440F-A756-7344771D99B8 Q37547141-8F362520-0ABA-4519-8130-45D7284F17F0 Q38185911-424AAA5B-E4E4-4880-B5C8-706E3D16283E Q38204033-4187CBB6-0CED-4E07-948A-A10724F5A5DE Q38303517-A4A28AF0-FA7A-4E7D-A3B7-6E21D2B0DC8C Q38847190-70C80D1E-FF04-48CC-8FA6-C32DEC44AB77 Q38849255-4B6EDADC-1AA4-40F3-985E-B4F44B7EE873 Q38962773-D43DD385-90C8-4829-9628-82FC58CE5FEB Q39278829-2D3B7BF7-EFBC-45CB-BC1F-776CF92A7A29 Q39320921-A4EEB38D-A625-44E4-980B-1CB11E9859EB Q40105761-76C33F79-E7CF-4A67-917C-775F990DE072 Q40109106-4DCC260D-01EC-4632-842D-1A860005F463 Q40319505-1E66567D-BEA5-4305-9AAF-05567C8370B7 Q40815694-BB3C14A6-ACD1-4194-8FA3-8CAB7E9E5C17 Q41093190-00D9B2F4-8E12-4ADB-84CE-2117A5C5BB43 Q41376422-CFB8AA37-66BA-4930-AFE7-B45312D4CAAF Q41730142-093D855D-7B65-4EF4-A7CC-33111A27A71F Q41769919-36CD570D-71EB-4D5C-958D-75916FC30B68 Q44169836-EE55C075-813F-4FFF-9EB7-37DCF69EA144 Q50994425-25F1A9C1-FD0F-4E5A-B864-23D22F674241 Q51007398-C13B9C61-89D3-464F-93B0-BBF068F17DEA Q52659333-E4B4B02C-F72E-4252-A222-DA4E6757C3F2 Q56157155-13827BFF-DA5F-43D8-A0DA-F7D0FF6C5301 Q59136268-3CE8C5EF-2E80-45B9-815B-A89B18CC9975

P2860

DNA vaccines: designing strategies against parasitic infections

http://www.wikidata.org/entity/Q24801950

description

2004 nî lūn-bûn

@nan

2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

DNA vaccines: designing strategies against parasitic infections

@ast

DNA vaccines: designing strategies against parasitic infections

@en

DNA vaccines: designing strategies against parasitic infections

@nl

type

label

DNA vaccines: designing strategies against parasitic infections

@ast

DNA vaccines: designing strategies against parasitic infections

@en

DNA vaccines: designing strategies against parasitic infections

@nl

prefLabel

DNA vaccines: designing strategies against parasitic infections

@ast

DNA vaccines: designing strategies against parasitic infections

@en

DNA vaccines: designing strategies against parasitic infections

@nl

P1433

Q24801950-78A035E7-F744-44EE-9BA3-1AAA8AD6C7A4

P1476

Q24801950-656C8B43-5561-43E7-9F77-CA212F53601F

P2093

Q24801950-85128BEC-006A-405C-99CA-4164F8132BAD

Q24801950-CEE00E91-90C4-476B-AC1C-A964D234CC41

P2860

Q24801950-0158389A-99A2-4610-BA2A-34C5A6DDC9C8

Q24801950-01CAC0EF-C23D-4F15-85F0-B02212585FDB

Q24801950-06F8AD92-0855-4F8D-BD86-AC5290040D29

Q24801950-0BBDCDA7-DA24-4F05-A086-843748CC2DA5

Q24801950-180AE20E-B189-4E0B-A4DC-507EFF194B2E

Q24801950-182853F0-1A71-4DE9-AEC4-1D042D83C2F6

Q24801950-1DA9933D-7411-475C-8F0D-B7A0A852BF1F

Q24801950-1F2CD58C-09A9-4C16-BBC2-2D6C891CA314

Q24801950-26A42907-EF80-4D3D-A476-234B437ADBBE

Q24801950-2913CF0C-8581-47F7-9890-DFB35B2E732B

P2888

Q24801950-37324690-03E5-4E49-9C68-ED8C5E31DE6F

P304

Q24801950-95E9ACBE-6F3D-4177-9B49-850FE076BE61

P31

Q24801950-08F0E086-B8E6-47D5-99CC-48ACBFDBAD78

P356

Q24801950-DC2A6A66-295A-43A3-93A8-3CC07785A236

P433

Q24801950-FCB15AF6-A9F6-4379-BC72-8A3CBA8B96FA

P478

Q24801950-DBF621F6-57E9-4500-BB0D-A6C7F029AD56

P577

Q24801950-571F8038-8074-44CA-8DC2-24C08D773613

P5875

Q24801950-F8C9F849-21A0-4E8B-BDB0-3195A239A8E6

P6179

Q24801950-E8D0AD1E-1241-4889-AF24-CAA20691578A

P698

Q24801950-5E6047D2-C796-4076-9EC5-280C3869CD8C

P932

Q24801950-0706CF8B-3498-4F81-8B94-10A82781A4BD

P356

P1433

Genetic Vaccines and Therapy

P1476

DNA vaccines: designing strategies against parasitic infections

@en

P2093

Catherine Ivory

http://www.w3.org/2001/XMLSchema#string

Kris Chadee

http://www.w3.org/2001/XMLSchema#string

P2860

Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques

Immunostimulatory effect of IL-18-encoding plasmid in DNA vaccination against murine Schistosoma mansoni infection.

Immune deviation as a strategy for schistosomiasis vaccines designed to prevent infection and egg-induced immunopathology.

The prime-boost strategy: exciting prospects for improved vaccination.

Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus.

Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice.

Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c mice

Heterologous priming-boosting immunization of cattle with Mycobacterium tuberculosis 85A induces antigen-specific T-cell responses.

Induction of protective immunity against Schistosoma mansoni via DNA priming and boosting with the large subunit of calpain (Sm-p80): adjuvant effects of granulocyte-macrophage colony-stimulating factor and interleukin-4.

A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.

P2888

P304

17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-0556-2-17

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2004-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8149041

http://www.w3.org/2001/XMLSchema#string

P6179

1039294500

http://www.w3.org/2001/XMLSchema#string

P698

15579202

http://www.w3.org/2001/XMLSchema#string

P932

544584

http://www.w3.org/2001/XMLSchema#string